The global aptamers market size is anticipated to expand at a robust CAGR during the forecast period, 2021-2028. The growth of the market is attributed to numerous advantages offered by these small molecules in comparison to established antibodies.
Aptamer is an artificial chemical antibody that is generated from the randomized nucleic acid library by three simple steps, which are binding, separation, and amplification. The selected aptamer has a high binding affinity with the target molecule. In most cases, aptamer was found to be better than other antibodies.
Aptamers are short, single-stranded DNA or RNA molecules that can selectively bind to a specific target, including proteins, peptides, carbohydrates, small molecules, toxins, and even live cells. These molecules have a variety of shapes due to their tendency to form helices and single-stranded loops. The huge number of possible tertiary structures allow aptamers to bind with high affinity through van der Waals, hydrogen bonding, and electrostatic interactions, to peptides or protein targets.
Market Trends, Drivers, Restraints, and Opportunities:
Ongoing advancement in aptamer development technologies is a prominent driver that is expected to contribute to the growth of the global aptamers market.Increasing research and development expenditure is augment the aptamers market growth.Lack of awareness of these technologies in middle and low-income countries can act as major restraints of the market.Many aptamers have failed to meet the requisite safety and clinical studies. Thus, companies had to terminate their clinical investigation, which in turn, can hamper the market growth.The outbreak of COVID-19 had negatively impacted the aptamers market. However, the market is anticipated to recover soon.Aptamers are chemically synthesized, which eliminates batch-to-batch variation and demands less time for development. This factor can create lucrative opportunities for industry players during the forecast period.Key Players
Aptagen, LLCBase Pair Biotechnologies, Inc.NOXXON PharmaSomaLogic Inc.Aptamer GroupAM Biotechnologies LLCAptamer Sciences Inc.Aptus Biotech S.L.TriLink BioTechnologies Inc.Vivonics IncCompetitive Landscape
The major players of the market are Aptagen, LLC., Base Pair Biotechnologies, Inc., NOXXON Pharma, SomaLogic Inc., Aptamer Group, AM Biotechnologies LLC, Aptamer Sciences Inc., Aptus Biotech S.L., TriLink BioTechnologies Inc., and Vivonics Inc.
Companies are focusing on innovation, expansion, and acquisitions to expand their market share.
To Get a New Sample Request: https://growthmarketreports.com/request-sample/774
Contact Us
Growth Market ReportsPhone: +1 909 414 1393Email: sales@growthmarketreports.com Web: https://growthmarketreports.com
Sign in to leave a comment.